
Tacrolimus Ring-Opening Impurity 2 Lithium Salt
- Catalogue No.
- CSL-234491
- CAS No.
- Not assigned
- Molecular formula
- C44H71NO13
- Molecular weight
- 821.04 6.94
- Parent drug
- tacrolimus
- Product type
- Impurities
Quick quote · CSL-234491Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- (S)-1-(2-((2R,3R,5S,6R)-6-((1S,3S,5E,7R,10S,11R,12S,13E)-7-allyl-10,12-dihydroxy-14-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methoxy-3,5,11,13-tetramethyl-8-oxotetradeca-5,13-dien-1-yl)-2-hydroxy-5-methoxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate, lithium salt (1:1)
More tacrolimus products
All 112 →
(1E,3S,4R,5R,8R,9E,12S,14S)-8-allyl-5-hydroxy-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-14-methoxy-14-((2R,3S,5R)-3-methoxy-5-methyl-6-oxotetrahydro-2H-pyran-2-yl)-2,4,10,12-tetramethyl-7-oxotetradeca-1,9-dien-3-yl (S)-1-formylpiperidine-2-carboxylateCSL-195890
![Chemical structure of (3R,4E,6S,7R,10R,11E,14S,16S,17R,18S,20R,21R,28aS)-10-Allyl-7,21-dihydroxy-3-((1S,3S,4S)-4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-3H-17,21-epoxypyrido[2,1-c][1]oxa[4]azacyclopentacosine-1,9,22,23(6H,25H)-tetraone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R4E6S7R10R11E14S16S17R18S20R21R28aS-10-Allyl-721-dihydroxy-3-1S3S4S-4-hydroxy-3-methoxycyclohexyl-1618-dimethoxy-46121420-pentamethyl-781013141516171.png&w=3840&q=75)
(3R,4E,6S,7R,10R,11E,14S,16S,17R,18S,20R,21R,28aS)-10-Allyl-7,21-dihydroxy-3-((1S,3S,4S)-4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-3H-17,21-epoxypyrido[2,1-c][1]oxa[4]azacyclopentacosine-1,9,22,23(6H,25H)-tetraoneCSL-195384
![Chemical structure of (3R,4E,6S,7S,10R,11E,14S,16S,17R,18S,20R,21R,28aR)-10-Allyl-7,21-Dihydroxy-3-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-3H-17,21-epoxypyrido[2,1-c][1]oxa[4]azacyclopentacosine-1,9,22,23(6H,25H)-tetraone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R4E6S7S10R11E14S16S17R18S20R21R28aR-10-Allyl-721-Dihydroxy-3-1R3R4R-4-hydroxy-3-methoxycyclohexyl-1618-dimethoxy-46121420-pentamethyl-781013141516171.png&w=3840&q=75)
(3R,4E,6S,7S,10R,11E,14S,16S,17R,18S,20R,21R,28aR)-10-Allyl-7,21-Dihydroxy-3-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-3H-17,21-epoxypyrido[2,1-c][1]oxa[4]azacyclopentacosine-1,9,22,23(6H,25H)-tetraoneCSL-195382
![Chemical structure of (3S,4E,6S,7S,10R,11E,14S,16S,17R,18S,20R,21R,28aS)-10-Allyl-7,21-dihydroxy-3-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-3H-17,21-epoxypyrido[2,1-c][1]oxa[4]azacyclopentacosine-1,9,22,23(6H,25H)-tetraone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3S4E6S7S10R11E14S16S17R18S20R21R28aS-10-Allyl-721-dihydroxy-3-1S3R4R-4-hydroxy-3-methoxycyclohexyl-1618-dimethoxy-46121420-pentamethyl-781013141516171.png&w=3840&q=75)
(3S,4E,6S,7S,10R,11E,14S,16S,17R,18S,20R,21R,28aS)-10-Allyl-7,21-dihydroxy-3-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-3H-17,21-epoxypyrido[2,1-c][1]oxa[4]azacyclopentacosine-1,9,22,23(6H,25H)-tetraoneCSL-193989

